🔗 Share this article

Chancellor Rachel Reeves has revealed she is preparing "specific steps to tackle household expense issues" in the forthcoming financial statement.

Speaking to the BBC, she emphasized that reducing inflation is a shared task of both the administration and the Bank of England.

The UK's price growth is projected to be the most elevated among the G7 industrialized countries this calendar year and next.

Possible Energy Bill Measures

Sources suggest the government could intervene to bring down energy bills, for instance by slashing the current 5% level of value-added tax charged on energy.

Another option is to lower some of the regulatory levies presently included in bills.

Fiscal Limitations and Expert Predictions

The administration will receive the next report from the official forecaster, the OBR, on Monday, which will clarify how much scope there is for these measures.

The view from most analysts is that Reeves will have to introduce tax rises or expenditure reductions in order to meet her self-imposed borrowing rules.

Earlier on the same day, calculations showed there was a twenty-two billion pound gap for the Treasury chief to resolve, which is at the lower end of projections.

"There's a shared job between the central bank and the administration to bear down further on some of the causes of price increases," the Chancellor told the BBC in Washington, at the conferences of the IMF and global financial institution.

Tax Pledges and International Concerns

While a great deal of the attention has been on likely tax increases, the chancellor said the latest figures from the OBR had not altered her pledge to campaign commitments not to increase tax levels on earnings tax, sales tax or social security contributions.

She blamed an "uncertain world" with increasing geopolitical and trade issues for the fiscal revenue measures, probably to be targeted on those "with the broadest shoulders."

Global Economic Disputes

Addressing apprehensions about the UK's trade ties with the Asian nation she said: "Our national security always are paramount."

Last week's declaration by Chinese authorities to tighten trade restrictions on rare earths and other resources that are essential for advanced tech manufacturing led US President Donald Trump to propose an additional 100% tariff on goods from the Asian country, increasing the prospect of an all-out trade war between the two economic giants.

The American finance chief labeled the Chinese action "commercial pressure" and "a global supply chain power grab."

Questioned on considering the US offer to participate in its dispute with the Asian nation, the Chancellor said she was "very concerned" by Chinese actions and encouraged the Chinese government "to avoid restrictions and limit trade."

She said the decision was "harmful for the world economy and causes additional headwinds."

"It is my opinion there are sectors where we should confront China, but there are also significant opportunities to sell into China's economy, including banking sector and other sectors of the economic system. We've got to achieve that equilibrium right."

The Treasury chief also stated she was cooperating with international partners "regarding our own critical minerals approach, so that we are less reliant."

Health Service Medicine Pricing and Funding

Reeves also recognized that the cost the NHS pays for drugs could go up as a consequence of current talks with the US government and its pharmaceutical firms, in exchange for reduced taxes and funding.

A number of the world's largest pharmaceutical manufacturers have said recently that they are either delaying or abandoning investments in the UK, with several attributing the insufficient payments they are obtaining.

Recently, the government science advisor said the cost the NHS pays for medicines would have to increase to prevent firms and drug research funding leaving the United Kingdom.

The Chancellor told the BBC: "It has been observed as a result of the cost structure, that clinical trials, new drugs have not been offered in the United Kingdom in the extent that they are in other EU nations."

"The objective is to make sure that patients getting treatment from the National Health Service are can obtain the finest critical drugs in the globe. And so we are examining these issues, and... seeking to attract additional funding into Britain."